GlassScriptPhysician profile
Benito Pataroque
NPI 1033100714
$14,765.04
in general payments reported to CMS, 2019-2025
37 companies · $2,309 in 2025
The $2,309 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,718 · 2020: $1,916 · 2021: $2,399 · 2022: $1,836 · 2023: $2,352 · 2024: $2,234 · 2025: $2,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,857 · Education: $38.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,857.17 |
| Education | $38.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,106.55 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,609.72 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,594.90 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $1,114.07 | 2019-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $1,057.99 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,048.29 | 2021-2024 | |
| Lilly USA, LLC | $1,014.16 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| E.R. Squibb & Sons, L.L.C. | $626.43 | 2019-2024 | Eliquis, Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $550.61 | 2022-2025 | |
| Edwards Lifesciences Corporation | $515.49 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.83 | 2019-2022 | |
| Amarin Pharma, INC. | $386.58 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $370.81 | 2023-2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $364.44 | 2019-2022 | |
| Exact Sciences Corporation | $252.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benito Pataroque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.